Product Details for: Imjudo
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
25MG/1.25ML (20MG/ML)
Single-Dose Vial
351(a)
Imjudo
Rx
002
Injection
Intravenous
300MG/15ML (20MG/ML)
Single-Dose Vial
351(a)
Imjudo
Rx
Proper Name
tremelimumab-actl
tremelimumab-actl
BLA Number
761289
761289
Applicant
AstraZeneca AB
AstraZeneca AB
Original Approval Date
October 21, 2022
October 21, 2022
Date of First Licensure